natgillin/translations-raw huggingface dataset:
Following the amendment of Regulation (EC) No 751/2004 by Regulation (EC) No 1843/2004, the operative event for the exchange rate for 2004 in the Czech Republic, Estonia, Cyprus, Latvia, Lithuania, Hungary, Malta, Poland, Slovenia and Slovakia for the purposes of converting into national currency the area payment for nuts provided for in Chapter 4 of Title IV of Council Regulation (EC) No 1782/2003 [3], which establishes common rules for direct support schemes under the common agricultural policy and certain support schemes for farmers, and amends certain regulations, is fixed as the date of entry into force of the 2003 Treaty of Accession.
Po spremembi Uredbe (ES) št. 751/2004 z Uredbo (ES) št. 1843/2004 se operativni dogodek za devizni tečaj, ki je v uporabi leta 2004 na Češkem, v Estoniji, na Cipru, v Latviji, Litvi, na Madžarskem, Malti, Poljskem, v Sloveniji in Slovaški za menjavo v nacionalno valuto za plačilo na površino za lupinarje iz naslova IV poglavja 4 Uredbe Sveta (ES) št. 1782/2003 [3], ki določa tako skupna pravila za sheme neposrednih podpor v okviru skupne kmetijske politike kot tudi nekatere sheme podpor za kmete in spreminja nekatere uredbe, določi na dan začetka veljavnosti Pristopne pogodbe iz leta 2003.
Regulation (EC) No 1117/2004 does not refer to the area payment for nuts provided for in Chapter 4 of Title IV of Regulation (EC) No 1782/2003.
Uredba (ES) št. 1117/2004 se ne sklicuje na plačilo na površino za lupinarje iz naslova IV poglavja 4 Uredbe (ES) št. 1782/2003.
The rates fixed in the Annex thereto should, however, also apply to the area payment for nuts.
Vendar je treba določiti, da se davki, določeni v Prilogi Uredbe (ES) št. 1782/2003, uporabljajo tudi za plačilo na površino za lupinarje.
Regulation (EC) No 1117/2004 should therefore be amended accordingly,
Zato je treba spremeniti Uredbo (ES) št. 1117/2004 –
The following point (e) is added to the first subparagraph of Article 1 of Regulation (EC) No 1117/2004:
V prvem odstavku člena 1 Uredbe (ES) št. 1117/2004 se doda naslednja točka (e):
the area payment for nuts provided for in Chapter 4 of Title IV of Regulation (EC) No 1782/2003.’
plačilo na površino za lupinarje iz naslova IV poglavja 4 Uredbe (ES) št. 1782/2003.“.
Regulation as amended by Regulation (EC) No 1843/2004 (OJ L 322, 23.10.2004, p. 10).
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 1843/2004 (UL L 322, 23.10.2004, str. 10).
OJ L 217, 17.6.2004, p. 8.
UL L 217, 17.6.2004, str. 8.
Regulation as last amended by Regulation (EC) No 864/2004 (OJ L 161, 30.4.2004, p. 48).
Uredba, kakor je bila nazadnje nazadnje spremenjena z Uredbo (ES) št. 864/2004 (UL L 161, 30.4.2004, str. 48).
Commission Regulation (EC) No 1851/2004
Uredba Komisije (ES) št. 1851/2004
amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits for veterinary medicinal products in foodstuffs of animal origin
o spremembi Priloge I k Uredbi Sveta (EGS) št. 2377/90 o določitvi postopka Skupnosti za določanje najvišjih mejnih vrednosti ostankov zdravil za uporabo v veterinarski medicini v živilih živalskega izvora
Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin [1], and in particular Articles 7 and 8 thereof,
ob upoštevanju Uredbe Sveta (EGS) št. 2377/90 z dne 26. junija 1990 o določitvi postopka Skupnosti za določanje najvišjih mejnih vrednosti ostankov zdravil za uporabo v veterinarski medicini v živilih živalskega izvora [1] in zlasti členov 7 in 8 Uredbe,
In accordance with Regulation (EEC) No 2377/90, maximum residue limits should be established for all pharmacologically active substances that are used within the Community in veterinary medicinal products intended for administration to food-producing animals.
V skladu z Uredbo (EGS) št. 2377/90 morajo biti najvišje mejne vrednosti ostankov določene za vse farmakološko aktivne substance, ki se uporabljajo v Skupnosti v zdravilih za uporabo v veterinarski medicini, namenjenih živalim za proizvodnjo živil.
Maximum residue limits should be established only after the examination within the Committee for Veterinary Medicinal Products (CVMP) of all the relevant information concerning the safety of residues of the substance concerned for the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs.
Najvišje mejne vrednosti ostankov je treba določiti šele potem, ko Odbor za veterinarska zdravila (CVMP) preuči vse ustrezne podatke o varnosti ostankov zadevnih substanc za porabnike živil živalskega izvora in vpliv ostankov na industrijsko predelavo živil.
In establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be present, the relevant food obtained from the treated animal (‘target tissue’) as well as the nature of the residue that is relevant for the monitoring of residues (‘marker residue’).
Pri določanju najvišjih mejnih vrednosti za ostanke zdravil v živilih živalskega izvora je treba opredeliti živalske vrste, v katerih so ostanki lahko prisotni, s tem povezano hrano, pridobljeno iz zdravljene živali („ciljno tkivo“), prav tako pa tudi naravo ostanka, ki je pomembna za spremljanje ostankov („ostanek označevalca“).
For the control of residues, as provided for in appropriate Community legislation, maximum residue limits should usually be established for the target tissues of liver or kidney.
Za nadzor ostankov, kakor je predvideno v ustrezni zakonodaji Skupnosti, naj bi običajno bile najvišje mejne vrednosti ostankov določene za ciljna tkiva jeter ali ledvic.
However, liver and kidney are frequently removed from carcasses moving in international trade, and maximum residue limits should therefore also always be established for muscle or fat tissues.
Ker pa so jetra in ledvice pogosto odstranjene iz klavnih trupov, namenjenih za mednarodno trgovino, morajo biti najvišje mejne vrednosti ostankov vedno določene tudi za mišična ali maščobna tkiva.
In the case of veterinary medicinal products intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey.
V primeru zdravil za uporabo v veterinarski medicini, namenjenih nesnicam, molznicam ali čebelam, je treba določiti tudi najvišje mejne vrednosti ostankov za jajca, mleko ali med.
Regulation (EEC) No 2377/90 provides that the establishment of maximum residue limits shall in no way prejudice the application of other relevant Community legislation.
Uredba Sveta (EGS) št. 2377/90 zagotavlja, da določitev najvišjih mejnih vrednosti ostankov nikakor ne posega v uporabo druge pomembne zakonodaje Skupnosti.
Based on an opinion of the CVMP, Annex III of Regulation (EEC) No 2377/90 was amended by Commission Regulation (EC) No 997/1999 [2] to include provisional maximum residue limits for morantel, in order to allow for the completion of scientific studies, notably concerning the marker residue and the analytical method for the determination of residues of morantel in the target tissues.
Na podlagi mnenja CVMP je bila Priloga III k Uredbi (EGS) št. 2377/90 spremenjena z Uredbo Komisije (ES) št. 997/1999 [2], da bi zajela začasne najvišje mejne vrednosti ostankov za morantel, zato da se omogoči dokončanje znanstvenih raziskav, zlasti tistih, ki zadevajo ostanek označevalca in analitično metodo za določitev ostankov morantela v ciljnih tkivih.
These maximum residue limits were subsequently extended by Commission Regulation (EC) No 1322/2001 [3] to allow the applicant further time for completion of the requested studies.
Te najvišje mejne vrednosti ostankov so bile naknadno razširjene z Uredbo Komisije (ES) št. 1322/2001 [3], da bi zagotovile prijavitelju nadaljnji čas za dokončanje zahtevanih raziskav.
The requested data on the marker residue and the analytical method was evaluated by the CVMP and found to be not completely in accordance with the requirements laid down in Volume 8 of the Rules Governing Medicinal Products in the European Union.
Zahtevane podatke o ostanku označevalca in analitični metodi je ocenil CVMP in ugotovil, da niso popolnoma v skladu z zahtevami iz poglavja 8 Pravil, ki urejajo zdravila v Evropski uniji.
The method was nevertheless considered fully validated for muscle and milk and either kidney or liver for the species cattle and sheep.
Metoda je bila kljub temu v celoti upoštevana za mišice in mleko ter ledvice ali jetra za govedo in ovce.
The CVMP subsequently proposed to insert morantel in Annex II of Regulation (EEC) No 2377/90, with the motivation that residues of morantel depleted rapidly and therefore the establishment of maximum residue limits was not necessary for the protection of public health.
Ker ostanki morantela hitro izginejo in zato določitev najvišje mejne vrednosti ostanka ni nujna za zaščito javnega zdravja, je CVMP naknadno predlagal, da se morantel vstavi v Prilogo II k Uredbi (EGS) št. 2377/90.
As residues of morantel in foodstuff from treated animals may supersede the acceptable daily intake 24 hours after administration, it is considered necessary, for reasons of consumer safety and to allow adequate withdrawal periods to be established for veterinary medicinal products containing morantel, to establish maximum residues limits, taking account of the maximum residue limits previously established.
Ker ostanki morantela v živilih, pridobljenih iz zdravljenih živali, lahko presežejo sprejemljivo dnevno količino 24 ur po zaužitju, je zaradi varnosti potrošnika in zaradi zagotovitve primernega časovnega umika, ki je določen za veterinarska zdravila z vsebnostjo morantela, treba določiti najvišje mejne vrednosti, ki so bile poprej določene.
Morantel is a pharmacologically active anthelmintic substance which has been in use in veterinary medicinal products for food-producing animal species for a considerable time for treatment against roundworms and tapeworms.
Morantel je farmakološko aktivna substanca (antelmintik), ki se že nekaj časa uporablja v veterinarskih zdravilih za zdravljenje valjastih črvov in trakulj pri živalih za proizvodnjo živil.
In view of the possible development of resistance, it is considered that access to multiple choices for treatment should remain possible.
Ob upoštevanju možnega razvoja odpornosti se šteje dostop do različnih načinov zdravljenja še vedno za možnega.
According to Regulation (EC) No 178/2002 [4], risk management shall take into account the results of risk assessment and other factors legitimate to the matter under consideration, such as detection methods and feasibility of controls for the purpose of avoiding risks from such substances.
Glede na Uredbo Evropskega parlamenta in Sveta (ES) št. 178/2002 [4] obvladovanje tveganja upošteva rezultate ocene tveganja in drugih dejavnikov, pomembnih za obravnavano zadevo, kot so metode odkrivanja in možnost kontrole za izogibanje tveganja pri tovrstnih substancah.
The relevant Community Reference Laboratory has confirmed that the methods proposed by the applicant can be made applicable for confirmatory analyses of morantel in the target tissues.
Ustrezen referenčni laboratorij Skupnosti je potrdil, da se metode, ki jih je predlagal prosilec, lahko začnejo uporabljati za potrditvene analize morantela v ciljnih tkivih.
The Commission considers that it is appropriate to include morantel in Annex I for cattle and sheep to provide safeguards for the consumer and to allow relevant controls of morantel in foodstuffs of treated animals.
Komisija meni, da je primerno vključiti morantel v Prilogo I za govedo in ovce, da se zagotovi zaščita potrošnika ter dovoli primerne kontrole morantela v živilskih izdelkih iz zdravljenih živali.
A period of 60 days should be allowed before the entry into force of this Regulation in order to allow Member States to make any adjustments which may be necessary to the authorisations to place the veterinary medicinal products concerned on the market which have been granted in accordance with Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products [5].
Omogočiti je treba rok 60 dni do začetka veljavnosti te uredbe, da lahko države članice dovoljenja za promet z zadevnimi zdravili za uporabo v veterinarski medicini, ki so bila izdana v skladu z Direktivo Evropskega parlamenta in Sveta 2001/82/ES o zakoniku Skupnosti o zdravilih za uporabo v veterinarski medicini [5], po potrebi prilagodijo določbam te uredbe.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products.
Ukrepi, predvideni s to uredbo, so v skladu z mnenjem Stalnega odbora za zdravila za uporabo v veterinarski medicini –
Annex I to Regulation (EEC) No 2377/90 is hereby amended as set out in the Annex hereto.
Priloga I k Uredbi (EGS) št. 2377/90 se spremeni, kakor je določeno v Prilogi k tej uredbi.
Regulation as last modified by Commission Regulation (EC) No 1646/2004 (OJ L 296, 21.9.2004, p. 5).
Uredba, kakor je bila nazadnje spremenjena z Uredbo Komisije (ES) št. 1646/2004 (UL L 296, 21.9.2004, str. 5).
OJ L 122, 12.5.1999, p. 24.
UL L 122, 12.5.1999, str. 24.
OJ L 177, 30.6.2001, p. 52.
UL L 177, 30.6.2001, str. 52.
Regulation as last modified by Regulation (EC) No 1642/2003 (OJ L 245, 29.9.2003, p. 4).
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 1642/2003 (UL L 245, 29.9.2003, str. 4).
Directive as amended by Directive 2004/28/EU (OJ L 136, 30.4.2004, p. 58).
Direktiva, kakor je bila nazadnje spremenjena z Direktivo 2004/28/ES (UL L 136, 30.4.2004, str. 58).
The following substance is inserted in Annex I to Regulation (EEC) No 2377/90:
Sledeča substanca se vstavi v Prilogo 1 I k Uredbi (EGS) št. 2377/90:
Tetrahydropyrimides
Tetrahidropirimidi
Pharmacologically active substance(s)
Farmakološko aktivna/-e substanca/-e
MRLs
Najvišja mejna vrednost ostanka
Sum of residues which may be hydrolysed to N-methyl-1,3- propanediamine and expressed as morantel equivalents
Vsota ostankov, ki se lahko hidrolizirajo v N-metil-1,3-propanediamin in so izraženi kot ekvivalenti morantela
Bovine, ovine
Govedo, ovce
Muscle
Mišice
Commission Regulation (EC) No 1852/2004
Uredba Komisije (ES) št. 1852/2004
It shall apply from 27 October to 9 November 2004.
Uporablja se od 27. oktobra do 9. novembra 2004.
to the Commission Regulation of 25 October 2004 fixing Community producer and import prices for carnations and roses with a view to the application of the arrangements governing imports of certain floricultural products originating in Cyprus, Israel, Jordan, Morocco and the West Bank and the Gaza Strip
k Uredbi Komisije z dne 25. oktobra 2004 o določitvi proizvodnih in uvoznih cen Skupnosti za nageljne in vrtnice z namenom uporabe uvoznega režima za nekatere cvetličarske izdelke s poreklom iz Cipra, Izraela, Jordanije, Maroka ter Zahodnega brega in Gaze
Period: from 27 October to 9 November 2004
Obdobje: od 27. oktobra do 9. novembra 2004
Council Regulation (EC) No 1853/2004
Uredba Sveta (ES) št. 1853/2004
concerning additional restrictive measures in respect of Burma/Myanmar and amending Regulation (EC) No 798/2004
o dodatnih omejevalnih ukrepih proti Burmi/Mjanmaru in spremembi Uredbe (ES) št. 798/2004
Having regard to the Treaty establishing the European Community, and in particular Articles 60 and 301 thereof,
ob upoštevanju Pogodbe o ustanovitvi Evropske skupnosti ter zlasti členov 60 in 301 Pogodbe,
Having regard to Council Common Position 2004/730/CFSP of 25 October 2004 on additional restrictive measures against Burma/Myanmar and amending Common Position 2004/423/CFSP [1],
ob upoštevanju Skupnega stališča Sveta 2004/730/SZVP o dodatnih omejevalnih ukrepih proti Burmi/Mjanmaru in o spremembi Skupnega stališča 2004/423/SZVP [1],
On 28 October 1996, the Council, concerned at the absence of progress towards democratisation and at the continuing violation of human rights in Burma/Myanmar, imposed certain restrictive measures against Burma/Myanmar by Common Position 1996/635/CFSP [2].
Zaradi zaskrbljenosti, ker ni bilo napredka pri demokratizaciji, in zaradi nenehnega kršenja človekovih pravic v Burmi/Mjanmaru, je Svet 28. oktobra 1996 s Skupnim stališčem 1996/635/SZVP [2] sprejel določene omejevalne ukrepe proti Burmi/Mjanmaru.
In view of the continuing severe and systematic violations of human rights by the Burmese authorities, and in particular the continuing and intensified repression of civil and political rights, and the failure of those authorities to take steps towards democracy and reconciliation, the restrictive measures against Burma/Myanmar have subsequently been extended several times, most recently by Common Position 2004/423/CFSP [3].
Kot posledica nenehnega hudega in sistematičnega kršenja človekovih pravic s strani burmanskih oblasti in še zlasti glede na stalno in okrepljeno zatiranje civilnih in političnih pravic ter neuspeha oblasti pri sprejemanju ukrepov za demokratizacijo in spravo, so bili omejitveni ukrepi proti Burmi/Mjanmaru večkrat podaljšani, nazadnje s Skupnim stališčem 2004/423/SZVP [3].
Some of the restrictive measures imposed against Burma/Myanmar have been implemented at Community level by Council Regulation (EC) No 798/2004 of 26 April 2004 renewing the restrictive measures in respect of Burma/Myanmar and repealing Regulation (EC) No 1081/2000 [4].
Nekateri omejevalni ukrepi proti Burmi/Mjanmaru so bili na ravni Skupnosti izvedeni z Uredbo Sveta (ES) št. 798/2004 z dne 26. aprila 2004 o podaljšanju omejitvenih ukrepov proti Burmi/Mjanmaru in o razveljavitvi Uredbe (ES) št. 1081/2000 [4].
In view of the current political situation in Burma/Myanmar, as witnessed by the failure of the military authorities to release Daw Aung San Suu Kyi and other members of the National League for Democracy (NLD) as well as other political detainees, and the failure to allow a genuine and open National Convention, and in view of the the continued harassment of the NLD and other organised political movements, Common Position 2004/730/CFSP maintains and strengthens the restrictive measures imposed in respect of Burma/Myanmar by Common Position 2004/423/CFSP to include, inter alia, a prohibition on making financial loans or credits available to, and on acquiring or extending a participation in, Burmese state-owned enterprises; while such prohibition should not affect the execution of related obligations resulting from existing contracts or agreements, the conclusion of new contracts or agreements on the subject-matter of this Regulation or the renewal of existing contracts or agreements after their expiration should be prohibited after the entry into force of this Regulation.
Glede na trenutne politične razmere v Burmi/Mjanmaru, o katerih priča dejstvo, da vojaške oblasti niso izpustile Daw Aung San Suu Kyi in drugih članov Narodne lige za demokracijo (NLD), kot tudi drugih političnih zapornikov, in niso omogočile dejanskega in odprtega delovanja Narodne konvencije, ter glede na nenehno nadlegovanje NLD in drugih organiziranih političnih gibanj, Skupno stališče 2004/730/SZVP ohranja in zaostruje omejevalne ukrepe, uvedene s Skupnim stališčem 2004/423/SZVP, proti Burmi/Mjanmaru tako, da med drugim vključuje prepoved dajanja finančnih posojil ali kreditov ter pridobivanja ali povečevanja deležev v burmanskih podjetjih v državnih lasti. Čeprav naj ta prepoved ne vpliva na izpolnitev obveznosti, ki izhajajo iz obstoječih pogodb ali sporazumov, pa naj bo prepovedano sklepanje novih pogodb ali sporazumov o zadevah, ki so predmet te uredbe, ali obnovitev obstoječih pogodb ali sporazumov po njihovem preteku po začetku veljavnosti te uredbe.
These measures fall within the scope of the Treaty and, therefore, in order to avoid any distortion of competition, Community legislation is necessary to implement them as far as the Community is concerned.
Ti ukrepi spadajo na področje uporabe Pogodbe in mora zato za njihovo izvedbo Skupnost v izogib izkrivljanju konkurence sprejeti zakonodajo Skupnosti.
In order to ensure that the measures provided for in this Regulation are effective, this Regulation should enter into force on the day of its publication.
Da bi zagotovili učinkovitost ukrepov iz te uredbe, mora ta uredba začeti veljati z dnem objave.
Regulation (EC) No 798/2004 should be amended accordingly,
Uredbo (ES) št. 798/2004 je treba ustrezno spremeniti –
Regulation (EC) No 798/2004 is hereby amended as follows:
Uredba (ES) št. 798/2004 se spremeni:
‘Article 8a
„Člen 8a
the granting of any financial loan or credit to Burmese state-owned enterprises as listed in Annex IV, or the acquisition of bonds, certificates of deposit, warrants or debentures, issued by these enterprises,
odobravanje kakršnih koli finančnih posojil ali kreditov burmanskim podjetjem v državni lasti, ki so našteta v Prilogi IV, ali pridobivanje delnic, potrdil o vlogah, lastniških certifikatov ali zadolžnic, ki jih izdajajo ta podjetja;
the acquisition or extension of a participation in Burmese state-owned enterprises as listed in Annex IV, including the acquisition in full of such enterprises and the acquisition of shares and securities of a participating nature.
pridobivanje ali povečevanje lastniških deležev v burmanskih podjetjih v državni lasti, ki so našteta v Prilogi IV, vključno z nakupom teh podjetij v celoti ali z nakupom delnic in lastniških vrednostnih papirjev.
The participation, knowingly and intentionally, in activities, the object or effect of which is, directly or indirectly, to circumvent the provisions of paragraph 1 shall be prohibited.
Zavestno in namerno sodelovanje pri dejavnostih, katerih namen ali učinek je neposredno ali posredno izogibanje določbam odstavka 1, je prepovedano.
Paragraph 1 shall be without prejudice to the execution of trade contracts for the supply of goods or services on usual commercial payment conditions and the usual supplementary agreements in connection with the execution of these contracts such as export credit insurances.
Odstavek 1 ne posega v izpolnitev trgovskih pogodb za dobavo blaga ali storitev po običajnih poslovnih plačilnih pogojih in običajnih dopolnilnih dogovorih v zvezi z izpolnitvijo teh pogodb, kot so izvozna kreditna zavarovanja.
The provisions of paragraph 1(a) shall be without prejudice to the execution of an obligation arising from contracts or agreements concluded before the entry into force of this Regulation.
Določbe odstavka 1(a) ne posegajo v izpolnitev obveznosti, ki izhajajo iz pogodb ali dogovorov, sklenjenih pred začetkom veljavnosti te uredbe.
The prohibition in paragraph 1(b) shall not prevent the extension of a participation in Burmese State-owned enterprises as listed in Annex IV, if such extension is compulsory under an agreement concluded with the Burmese State-owned enterprise concerned before the entry into force of this Regulation.
Prepoved iz odstavka 1(b) ne preprečuje povečanja lastniškega deleža v burmanskih podjetjih v državni lasti, ki so našteta v Prilogi IV, če je to povečanje obvezno na podlagi dogovora, sklenjenega z zadevnim burmanskim podjetjem v državni lasti pred začetkom veljavnosti te uredbe.
The relevant competent authority, as listed in Annex II, and the Commission shall be informed prior to any such transaction.
Pred vsako takšno transakcijo je treba obvestiti ustrezen pristojni organ iz Priloge II in Komisijo.
The Commission shall inform the competent authorities of the other Member States.’;
Komisija obvesti pristojne organe drugih držav članic.“;
Article 12 shall be replaced by the following:
člen 12 se nadomesti z naslednjim:
The Commission shall be empowered to:
Komisija je pooblaščena za:
amend Annex II on the basis of information supplied by Member States,
spreminjanje Priloge II na podlagi informacij, ki jih posredujejo države članice,